Literature DB >> 10338054

Cortical blindness and seizures in a patient receiving FK506 after bone marrow transplantation.

R E Steg1, A Kessinger, Z K Wszolek.   

Abstract

A 54-year-old woman with a myelodysplastic syndrome treated with high-dose chemotherapy and an allogenic bone marrow transplant developed acute cortical blindness while receiving tacrolimus (FK506). MRI showed white matter abnormalities. After discontinuation of FK506, the patient's vision returned within 8 days. FK506 neurotoxicity is similar to cyclosporine neurotoxicity and can occur in allogenic bone marrow transplant patients treated with FK506.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10338054     DOI： 10.1038/sj.bmt.1701732

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


  9 in total

1.  Tacrolimus.

Authors:  D B Lake; T R G Poole
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

2.  Benign cerebral angiopathy; postpartum cerebral angiopathy: characteristics and treatment.

Authors:  Sofia Calado; Miguel Viana-Baptista
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-05

3.  Postpartum angiopathy and other cerebral vasoconstriction syndromes.

Authors:  Aneesh B Singhal; Richard A Bernstein
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

4.  Reversible tacrolimus-induced neurotoxicity isolated to the brain stem.

Authors:  P J Oliverio; L Restrepo; S A Mitchell; C S Tornatore; S R Frankel
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

5.  A case of reversible toxic optic neuropathy from tacrolimus (FK506).

Authors:  Kimberly K Gokoffski; Vivek R Patel
Journal:  Am J Ophthalmol Case Rep       Date:  2020-09-16

6.  A Case of Tacrolimus Maculopathy.

Authors:  Martina Santarelli; Marco Zeppieri; Carlo Salati
Journal:  Clin Pract       Date:  2022-05-01

7.  Tacrolimus-induced unilateral ischaemic optic neuropathy in a non-transplant patient.

Authors:  Monika Gupta; Reema Bansal; Nikhil Beke; Amod Gupta
Journal:  BMJ Case Rep       Date:  2012-08-21

8.  Successful treatment of tacrolimus (FK506)-related leukoencephalopathy with cerebral hemorrhage in a patient who underwent nonmyeloablative stem cell transplantation.

Authors:  Hiroya Tamaki; Manabu Kawakami; Kazuhiro Ikegame; Kenichiro Iio; Yu Harada; Kazuo Hatanaka; Yoshihiro Oka; Ichiro Kawase; Hiroyasu Ogawa
Journal:  Int J Hematol       Date:  2004-10       Impact factor: 2.490

9.  Maculopathy associated with tacrolimus (FK 506).

Authors:  Taehyuk Koh; Seung-Hee Baek; Jung Il Han; Ungsoo Samuel Kim
Journal:  Korean J Ophthalmol       Date:  2011-01-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.